Continuous infusion of high‐dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study

BACKGROUND: Ulinastatin can prevent the perioperative increase in proinflammatory cytokines for lung resection surgery; however, its impact on early clinical outcomes remains unknown. METHODS: The study enrolled 108 non‐small cell lung cancer (NSCLC) patients who were randomly allocated into two gro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Zhou, Leng, Lan, Haidan, Zhou, Qinghua, Tang, Xiao Jun, Zhu, Daxing, Yue, Jianming, Liu, Bin
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129221/
https://ncbi.nlm.nih.gov/pubmed/27766771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars